ketanserin has been researched along with Myelopathy in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " dosage again displayed significant efficacy when administered at 15 min delaying treatment to 30 min resulted in only marginal therapeutic actions." | 1.29 | Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment. ( Agresta, CA; Azim, S; Chavin, J; Kelly, G; Puniak, MA; Salzman, SK; Wang, L, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salzman, SK | 1 |
| Kelly, G | 1 |
| Chavin, J | 1 |
| Wang, L | 1 |
| Puniak, MA | 1 |
| Agresta, CA | 1 |
| Azim, S | 1 |
1 other study available for ketanserin and Myelopathy
| Article | Year |
|---|---|
Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
Topics: Animals; Dose-Response Relationship, Drug; Drug Administration Routes; Edema; Ketanserin; Male; Mian | 1994 |